Suppr超能文献

肝样腺癌鉴别诊断的临床病理特征:文献复习。

Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review.

机构信息

Division of Gastroenterology and Hepatology, Kuang Tien General Hospital, Taichung 433, Taiwan.

出版信息

World J Gastroenterol. 2013 Jan 21;19(3):321-7. doi: 10.3748/wjg.v19.i3.321.

Abstract

Hepatoid adenocarcinoma (HAC) is a rare but important special type of extrahepatic adenocarcinoma with clinicopathological presentation mimicking hepatocellular carcinoma (HCC), and prompt and correct diagnosis can be a challenge, especially in endemic areas with a high incidence of HCC. To date, HAC has only been reported in case series or single case reports, so we aimed to review the clinicopathological characteristics of HAC to obtain a more complete picture of this rare form of extrahepatic adenocarcinoma. All the articles about HAC published from 2001 to 2011 were reviewed, and clinicopathological findings were extracted for analysis. A late middle-aged male with high serum α-fetoprotein and atypical image finding of HCC should raise the suspicion of HAC, and characteristic pathological immunohistochemical stains can help with the differential diagnosis. Novel immunohistochemical markers may be useful to clearly differentiate HAC from HCC. Once metastatic HAC is diagnosed, the primary tumor origin should be identified for adequate treatment. The majority of HAC originates from the stomach, so panendoscopy should be arranged first.

摘要

肝样腺癌(Hepatoid adenocarcinoma,HAC)是一种罕见但重要的肝外腺癌特殊类型,其临床表现类似于肝细胞癌(Hepatocellular carcinoma,HCC),因此及时、准确的诊断具有一定挑战性,尤其是在 HCC 发病率较高的流行地区。迄今为止,HAC 仅在病例系列或单个病例报告中有所报道,因此我们旨在回顾 HAC 的临床病理特征,以更全面地了解这种罕见的肝外腺癌。对 2001 年至 2011 年间发表的所有关于 HAC 的文章进行了回顾,并提取了临床病理发现进行分析。对于血清甲胎蛋白(α-fetoprotein,AFP)水平较高且 HCC 的影像学表现不典型的中老年男性,应高度怀疑 HAC,而特征性的病理免疫组织化学染色有助于鉴别诊断。新型免疫组织化学标志物可能有助于明确区分 HAC 和 HCC。一旦诊断为转移性 HAC,应确定原发肿瘤的来源,以便进行充分的治疗。大多数 HAC 来源于胃,因此应首先安排全内镜检查。

相似文献

1
Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review.
World J Gastroenterol. 2013 Jan 21;19(3):321-7. doi: 10.3748/wjg.v19.i3.321.
4
Case Report of an Hepatoid Adenocarcinoma of the Stomach.
Appl Immunohistochem Mol Morphol. 2016 Feb;24(2):e6-8. doi: 10.1097/PAI.0000000000000286.
5
Hepatoid adenocarcinoma of the lung: Review of a rare form of lung cancer.
Respir Med. 2016 Oct;119:175-179. doi: 10.1016/j.rmed.2016.09.003. Epub 2016 Sep 3.
6
Atypical Presentation of Hepatocellular Carcinoma Mimicking a Gastric Hepatoid Adenocarcinoma: A Case Report.
Medicine (Baltimore). 2015 Jul;94(27):e1101. doi: 10.1097/MD.0000000000001101.
7
Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
Cancer Lett. 2023 Apr 10;559:216104. doi: 10.1016/j.canlet.2023.216104. Epub 2023 Mar 1.
9
[A case of hepatic metastasis of gastric hepatoid adenocarcinoma mistaken for primary hepatocellular carcinoma].
Korean J Gastroenterol. 2012 Oct;60(4):262-6. doi: 10.4166/kjg.2012.60.4.262.

引用本文的文献

1
A rare case of hepatoid adenocarcinoma of the lung initially presenting as a painful skin nodule.
J Surg Case Rep. 2025 Sep 8;2025(9):rjaf708. doi: 10.1093/jscr/rjaf708. eCollection 2025 Sep.
2
Non-Metastatic Pure Pancreatic Hepatoid Carcinoma with Genomic and Transcriptomic Analysis: A Case Report.
Case Rep Oncol. 2025 Feb 19;18(1):420-428. doi: 10.1159/000544747. eCollection 2025 Jan-Dec.
3
α‑Fetoprotein‑positive hepatoid adenocarcinoma of the stomach and a new classification: A case report.
Oncol Lett. 2024 Oct 3;28(6):586. doi: 10.3892/ol.2024.14717. eCollection 2024 Dec.
4
A case study of unexplained multiple hepatoid adenocarcinoma of the bone.
Quant Imaging Med Surg. 2024 Sep 1;14(9):7018-7023. doi: 10.21037/qims-24-321. Epub 2024 Aug 28.
6
New substituted molecular classifications of advanced gastric adenocarcinoma: characteristics and probable treatment strategies.
J Natl Cancer Cent. 2021 Nov 13;2(1):50-59. doi: 10.1016/j.jncc.2021.11.004. eCollection 2022 Mar.
9
CT Findings of Hepatic Metastasis from Hepatoid Adenocarcinoma of the Rectum Mimicking Hepatocellular Carcinoma: A Case Report.
J Korean Soc Radiol. 2024 Mar;85(2):409-414. doi: 10.3348/jksr.2023.0017. Epub 2023 Dec 26.

本文引用的文献

1
Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma.
World J Gastroenterol. 2011 Nov 7;17(41):4563-71. doi: 10.3748/wjg.v17.i41.4563.
2
Surgical approach for extrahepatic metastasis of HCC in the abdominal cavity.
Hepatogastroenterology. 2011 Nov-Dec;58(112):2067-70. doi: 10.5754/hge11188.
3
Management of hepatocellular carcinoma: an update.
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.
4
Serum biomarker panels for the detection of pancreatic cancer.
Clin Cancer Res. 2011 Feb 15;17(4):805-16. doi: 10.1158/1078-0432.CCR-10-0248.
5
Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach.
Am J Surg Pathol. 2010 Oct;34(10):1465-71. doi: 10.1097/PAS.0b013e3181f0a873.
7
Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach.
Mod Pathol. 2008 Apr;21(4):464-75. doi: 10.1038/modpathol.3801050. Epub 2008 Jan 18.
8
Two cases of hepatoid adenocarcinoma of the intestine in association with inflammatory bowel disease.
Histopathology. 2007 Jul;51(1):123-5. doi: 10.1111/j.1365-2559.2007.02715.x. Epub 2007 May 26.
9
Hepatoid adenocarcinoma of the gallbladder.
Dig Dis Sci. 2007 Dec;52(12):3358-62. doi: 10.1007/s10620-007-9807-3. Epub 2007 May 18.
10
Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
Hum Pathol. 2007 Jun;38(6):857-63. doi: 10.1016/j.humpath.2006.10.020. Epub 2007 Feb 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验